Collplant Biotechnologies Ltd
NASDAQ:CLGN
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Price:
6 USD
4.14%
Updated:
May 28, 2024
Collplant Biotechnologies Ltd
Operating Expenses
|
Collplant Biotechnologies Ltd
Operating Expenses Peer Comparison
Comparables:
KMDA
B
BLRX
URGN
ENTX
B
BONS
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Operating Expenses
-$16.5m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Operating Expenses
-$46.6m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-7%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Operating Expenses
-$44.1m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-10%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Operating Expenses
-$144.7m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Operating Expenses
-$8.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Operating Expenses
-₪29.8m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-12%
|
See Also
What is Collplant Biotechnologies Ltd's Operating Expenses?
Operating Expenses
-16.5m
USD
-16.5m
USD
Based on the financial report for Dec 31, 2023, Collplant Biotechnologies Ltd's Operating Expenses amounts to -16.5m USD.
What is Collplant Biotechnologies Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-17%
-17%
Over the last year, the Operating Expenses growth was 3%. The average annual Operating Expenses growth rates for Collplant Biotechnologies Ltd have been -24% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
